2221 related articles for article (PubMed ID: 19688669)
21. Value of wash-in and wash-out time in the diagnosis between hepatocellular carcinoma and other hepatic nodules with similar vascular pattern on contrast-enhanced ultrasound.
Kong WT; Wang WP; Huang BJ; Ding H; Mao F
J Gastroenterol Hepatol; 2014 Mar; 29(3):576-80. PubMed ID: 24118042
[TBL] [Abstract][Full Text] [Related]
22. Vascularization of liver tumors - preliminary results with Coded Harmonic Angio (CHA), phase inversion imaging, 3D power Doppler and contrast medium-enhanced B-flow with second generation contrast agent (Optison).
Jung EM; Kubale R; Jungius KP; Jung W; Lenhart M; Clevert DA
Clin Hemorheol Microcirc; 2006; 34(4):483-97. PubMed ID: 16687788
[TBL] [Abstract][Full Text] [Related]
23. Parametric imaging with contrast-enhanced ultrasound: usefulness for characterization of dynamic effects of microvascularization for hepatocellular carcinoma and focal nodular hyperplasia.
Zheng SG; Xu HX; Liu LN; Wang Y; Zhang YF; Guo LH; Liu C; Xu JM; Sun LP; Wu J
Clin Hemorheol Microcirc; 2013; 55(3):375-89. PubMed ID: 23271200
[TBL] [Abstract][Full Text] [Related]
24. Focal hepatic lesions: evaluation with contrast-enhanced gray-scale harmonic US.
Jang HJ; Lim HK; Lee WJ; Kim SH; Kim MJ; Choi D; Lee SJ; Lim JH
Korean J Radiol; 2003; 4(2):91-100. PubMed ID: 12845304
[TBL] [Abstract][Full Text] [Related]
25. Characterization of liver lesions by real-time contrast-enhanced ultrasonography.
Celli N; Gaiani S; Piscaglia F; Zironi G; Camaggi V; Leoni S; Righini R; Bolondi L
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):3-14. PubMed ID: 17206071
[TBL] [Abstract][Full Text] [Related]
26. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound.
Dietrich CF; Schuessler G; Trojan J; Fellbaum C; Ignee A
Br J Radiol; 2005 Aug; 78(932):704-7. PubMed ID: 16046421
[TBL] [Abstract][Full Text] [Related]
27. Focal nodular hyperplasia: spoke-wheel arterial pattern and other signs on dynamic contrast-enhanced ultrasonography.
Ungermann L; Eliás P; Zizka J; Ryska P; Klzo L
Eur J Radiol; 2007 Aug; 63(2):290-4. PubMed ID: 17353110
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
[TBL] [Abstract][Full Text] [Related]
29. 3D analysis is superior to 2D analysis for contrast-enhanced ultrasound in revealing vascularity in focal liver lesions - A retrospective analysis of 83 cases.
Dong FJ; Xu JF; Du D; Jiao Y; Zhang L; Li M; Liu HY; Xiong Y; Luo H
Ultrasonics; 2016 Aug; 70():221-6. PubMed ID: 27235776
[TBL] [Abstract][Full Text] [Related]
30. Liver tumor characterization--review of the literature.
Dietrich CF; Maddalena ME; Cui XW; Schreiber-Dietrich D; Ignee A
Ultraschall Med; 2012 Jul; 33 Suppl 1():S3-10. PubMed ID: 22723026
[TBL] [Abstract][Full Text] [Related]
31. Characterization of hepatic tumors: value of contrast-enhanced coded phase-inversion harmonic angio.
Wen YL; Kudo M; Zheng RQ; Ding H; Zhou P; Minami Y; Chung H; Kitano M; Kawasaki T; Maekawa K
AJR Am J Roentgenol; 2004 Apr; 182(4):1019-26. PubMed ID: 15039180
[TBL] [Abstract][Full Text] [Related]
32. [Accuracy of liver lesion assessment using automated measurement and segmentation software in biphasic multislice CT (MSCT)].
Puesken M; Juergens KU; Edenfeld A; Buerke B; Seifarth H; Beyer F; Suehling M; Osada N; Heindel W; Wessling J
Rofo; 2009 Jan; 181(1):67-73. PubMed ID: 18975251
[TBL] [Abstract][Full Text] [Related]
33. [Contrast-enhanced ultrasound in the diagnosis of benign and malignant hepatic tumors].
Jiang Y; Zhou Q; Zhu C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 37(1):53-6. PubMed ID: 22349380
[TBL] [Abstract][Full Text] [Related]
34. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
[TBL] [Abstract][Full Text] [Related]
35. Focal liver lesions in cirrhosis: value of contrast-enhanced ultrasonography compared with Doppler ultrasound and alpha-fetoprotein levels.
D'Onofrio M; Faccioli N; Zamboni G; Malagò R; Caffarri S; Fattovich G; Mucelli RP
Radiol Med; 2008 Oct; 113(7):978-91. PubMed ID: 18779929
[TBL] [Abstract][Full Text] [Related]
36. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
[TBL] [Abstract][Full Text] [Related]
37. Focal liver processes: "better is the enemy of good": CEUS in the fast lane.
Braun B
Ultraschall Med; 2009 Aug; 30(4):329-32. PubMed ID: 19688667
[No Abstract] [Full Text] [Related]
38. [Dynamic MRI of the liver with parallel acquisition technique: characterization of focal liver lesions and analysis of the hepatic vasculature in a single MRI session].
Heilmaier C; Sutter R; Lutz AM; Seifert B; Willmann JK
Rofo; 2008 May; 180(5):440-8. PubMed ID: 18438745
[TBL] [Abstract][Full Text] [Related]
39. Efficacy comparison of multi-phase CT and hepatotropic contrast-enhanced MRI in the differential diagnosis of focal nodular hyperplasia: a prospective cohort study.
Nowicki TK; Markiet K; Izycka-Swieszewska E; Dziadziuszko K; Studniarek M; Szurowska E
BMC Gastroenterol; 2018 Jan; 18(1):10. PubMed ID: 29334905
[TBL] [Abstract][Full Text] [Related]
40. Effect of fatty liver background on contrast-enhanced ultrasonographic appearance of focal nodular hyperplasia.
Lin LW; Yang JJ; Lin XY; Xue ES; He YM; Gao SD; Yang L; Yu LY
Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):610-5. PubMed ID: 18086627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
